Rates, Risks and Routes to Reduce Vascular Dementia (R4VaD)

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:0 publications

Grant number: C19-IUC-044

Grant search

Key facts

  • Disease

  • Funder

    UK Research and Innovation (UKRI)
  • Principle Investigator

  • Research Location

    United Kingdom, Europe
  • Lead Research Institution

    UK Dementia Research Institute
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Prognostic factors for disease severity

  • Special Interest Tags


  • Study Subject


  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment


  • Age Group


  • Vulnerable Population

    Individuals with multimorbidityOther

  • Occupations of Interest



Amendment to an existing UK-wide observational study of stroke and its cognitive and neuropsychiatric complications R4VaD, (as a high risk population for vascular dementia) to collect data on the impact of COVID-19 on stroke patients with vascular disease. These patients have higher risk of catching and having severe COVID disease, are often on ACE inhibitors which may affect their risk. Neurological complications have been reported in a third of COVID-19 infected patients, and patients already in R4VaD follow-up are reporting high levels of anxiety. All ethics, HRA and NRS approvals are in place; recruitment has commenced where resource is available.